Background: Prolonged heart rate-corrected QT (QTc) interval may reflect poor prognosis of patients with type 2 diabetes (T2D). Serum adenosine deaminase (ADA) levels are related to hyperglycemia, insulin resistance (IR) and inflammation, which may participate in diabetic complications. We investigated the association of serum ADA levels with prolonged QTc interval in a large-scale sample of patients with T2D.
Methods: In this cross-sectional study, a total of 492 patients with T2D were recruited. Serum ADA levels were determined by venous blood during fasting. QTc interval was estimated from resting 12-lead electrocardiograms, and prolonged QTc interval was defined as QTc > 440 ms.
Results: In this study, the prevalence of prolonged QTc interval was 22.8%. Serum ADA levels were positively associated with QTc interval (r = 0.324, p < 0.0001). The proportion of participants with prolonged QTc interval increased significantly from 9.2% in the first tertile (T1) to 24.7% in the second tertile (T2) and 39.0% in the third tertile (T3) of ADA (p for trend <0.001). After adjusting for other possible risk factors by multiple linear regression analysis, serum ADA level was still significantly associated with QTc interval (β = 0.217, t = 3.400, p < 0.01). Multivariate logistic regression analysis showed that female (OR 5.084, CI 2.379-10.864, p < 0.001), insulin-sensitizers treatment (OR 4.229, CI 1.290-13.860, p = 0.017) and ADA (OR 1.212, CI 1.094-1.343, p < 0.001) were independent contributors to prolonged QTc interval.
Conclusions: Serum ADA levels were independently associated with prolonged QTc interval in patients with T2D.